2022
DOI: 10.1016/j.cbi.2022.110228
|View full text |Cite
|
Sign up to set email alerts
|

Involvement of esterases in the pulmonary metabolism of beclomethasone dipropionate and the potential influence of cannabis use

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 46 publications
0
1
0
Order By: Relevance
“… [15] A laboratory-based study suggests that smoking cannabis decreases the conversion of beclomethasone dipropionate (BDP) to its active metabolite, beclomethasone-17- monopropionate. [16] The clinical significance of possible interactions between inhaled cannabis and BDP or other ICSs has not been studied. Cannabis has been reported to cause allergic manifestations, [17 , 18] including asthma, allergic rhinitis, eczema and even anaphylaxis.…”
Section: Editorialmentioning
confidence: 99%
“… [15] A laboratory-based study suggests that smoking cannabis decreases the conversion of beclomethasone dipropionate (BDP) to its active metabolite, beclomethasone-17- monopropionate. [16] The clinical significance of possible interactions between inhaled cannabis and BDP or other ICSs has not been studied. Cannabis has been reported to cause allergic manifestations, [17 , 18] including asthma, allergic rhinitis, eczema and even anaphylaxis.…”
Section: Editorialmentioning
confidence: 99%